Macrophage migration inhibitory factor -173 polymorphism and risk of coronary alterations in children with Kawasaki disease

Clinical and Experimental Rheumatology

Volumn 27, Issue 6, 2009, Pages 1026-1030

  Simonini, Gabriele ^a   Corinaldesi, Elena ^a   Massai, Cristina ^a   Falcini, Fernanda ^b   Fanti, Francesca ^a   De Martino, Maurizio ^a   Cimaz, Rolando ^a  

^a UNIVERSITY OF FLORENCE   (Italy)

^b UNIVERSITY OF FLORENCE   (Italy)

Author keywords

Coronary artery abnormalities; Kawasaki disease; Macrophage migration inhibitory factor

Indexed keywords

ACETYLSALICYLIC ACID; IMMUNOGLOBULIN; MACROPHAGE MIGRATION INHIBITION FACTOR; MACROPHAGE MIGRATION INHIBITORY FACTOR 173; METHYLPREDNISOLONE; UNCLASSIFIED DRUG;

ALLELE; ARTICLE; CARDIOVASCULAR RISK; CAUCASIAN; CHILD; CLINICAL EVALUATION; COHORT ANALYSIS; CONTINUOUS INFUSION; CORONARY ARTERY ANOMALY; CORONARY ARTERY DISEASE; DISEASE ACTIVITY; DISEASE COURSE; DISEASE PREDISPOSITION; DISEASE SEVERITY; DOPPLER ECHOCARDIOGRAPHY; ELECTROCARDIOGRAM; FEMALE; FEVER; GENE FREQUENCY; GENETIC POLYMORPHISM; GENOTYPE; HUMAN; INFUSION SYSTEM; ITALY; MAJOR CLINICAL STUDY; MALE; MUCOCUTANEOUS LYMPH NODE SYNDROME; MULTIPLE CYCLE TREATMENT; MULTIPLE REGRESSION; POLYMERASE CHAIN REACTION; PRESCHOOL CHILD; PRIORITY JOURNAL; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; SCHOOL CHILD; STEROID THERAPY; TWO DIMENSIONAL ECHOCARDIOGRAPHY;

ALLELES; CHILD; CHILD, PRESCHOOL; CORONARY VESSEL ANOMALIES; FEMALE; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; IMMUNOGLOBULINS, INTRAVENOUS; INFANT; ITALY; MACROPHAGE MIGRATION-INHIBITORY FACTORS; MALE; MUCOCUTANEOUS LYMPH NODE SYNDROME; MUTATION; POLYMERASE CHAIN REACTION; POLYMORPHISM, SINGLE NUCLEOTIDE; RISK FACTORS; SEVERITY OF ILLNESS INDEX;

EID: 76649110194     PISSN: 0392856X     EISSN: 1593098X     Source Type: Journal    
DOI: None     Document Type: Article

References (23)

1. NEWBURGER JW, BURNS JC, TAKAHASHI M et al.: Diagnosis, treatment, and long-term management of Kawasaki disease. Circulation 2004; 110: 2747-71.
2. BURNS JC, GLODE' MP: Kawasaki syndrome. Lancet 2004; 364: 533-41.
3. BAUGH JA, BUCALA R: Macrophage migration inhibitory factor. Crit Care Med 2002; 30 (Suppl 1): 27-35.
4. RENNER P, ROGER T, CALANDRA T: Macrophage migration inhibitor factor: gene polymorphisms and susceptibility to inflammatory diseases. CID 2005; 41 (Suppl 7): 513-9.
5. LEE TJ, CHUNG JK, YEON SI, SHIN JS, KIM DS: Increased serum levels of macrophage migration inhibitory factor in patients with Kawasaki Disease. Scand J Rheumatol 2007; 36: 222-5.
6. BAUGH JA, CHITINIS S, DONNELLY SC et al.: A functional promoter polymorphism in the macrophage migration inhibitory factor (MIF) gene associated with disease severity in rheumatoid arthritis. Genes Immun 2002; 3: 170-6.
7. VIVARELLI M, D'URBANO LE, INSALACO A et al.: Macrophage migration inhibitory factor (MIF) and oligoarticular juvenile idiopathic arthritis (o-JIA): association of MIF promoter polymorphisms with response to intrarticular glucocorticoids. Clin Exp Rheumatol 2007; 25: 775-81.
8. DONN R, ZEGGINI E, MEAZZA C et al.: A functional promoter haplotype of macrophage migration inhibitory factor is linked and associated with juvenile idiopathic arthritis. Arthritis Rheum 2004; 50: 1604-10.
9. DONN RP, SHELLEY E, OLLIER WER, THOMSON W, BRITISH PAEDIATRIC RHEUMATOLOGY STUDY GROUP: A novel 5′-flanking region polymorphisms of macrophage migration inhibitory factor is associated with systemiconset Juvenile Idiopathic Arthritis. Arthritis Rheum 2001; 44: 1782-5.
10. DE BENEDETTI F, MEAZZA C, VIVARELLI M et al.: Functional and prognostic relevance of the -173 polymorphism of the macrophage migration inhibitory factor in systemic-onset juvenile idiopathic arthritis. Arthritis Rheum 2003; 48: 1398-407.
11. DONN R, ALOURFI Z, DE BENEDETTI F et al.: Mutation screening of the macrophage migration inhibitory factor gene: positive association of a functional polymorphism of macrophage migration inhibitory factor with juvenile idiopathic arthritis. Arthritis Rheum 2002; 46: 2402-9.
12. DE ZORZI A, COLAN SD, GAUVREAU K, BAKER AL, SUNDEL RP, NEWBURGER JW: Coronary artery dimension may be misclassified as normal in Kawasaki disease. J Pediatr 1998; 133: 254-8.
13. BERDELI A, OZYUREK AR, ULGER Z et al.: Association of macrophage inhibitory factor gene -173 G/C polymorphism with prognosis in Turkish children with juvenile rheumatoid arthritis. Rheumatol Int 2006; 26: 726-31.
14. FAUL F, ERDFELDER E, LANG AG, BUCHNER A: G*POWER 3: A flexible statistical power analysis program for the social, behavioral, and biomedical sciences. Behavior Research Methods 2007; 39: 175-91.
15. COHEN J: 1988. Statistical power analysis for the behavioral sciences (2nd ed.). Hillsdale, NJ: Lawrence Erlbaum Associates.
16. LIN SG, YU XY, CHEN YX et al.: De novo expression of macrophage migration inhibitory factor in atherogenesis in rabbits. Circ Res 2000; 87: 1202-8.
17. PAN JH, LINDHOLT JS, SUKHOVA GK, BAUGH JA, HENNEBERG EW, BUCALA R: Macrophage migration inhibitory factor is associated with aneurismal expansion. J Vasc Surg 2003; 37: 628-35.
18. CHEN Z, SAKUMA M, ZAGO AC et al.: Evidence for a role of macrophage migration inhibitory factor in vascular disease. Arterioscler Thromb Vasc Biol 2004; 24: 709-14.
19. JIM HS, KIM HB, KIM BS et al.: The IL-10 (-627 A/C) promoter polymorphism may be associated with coronary aneurysms and low serum albumin in Korean children with Kawasaki disease. Pediatric Res 2007;61: 584-87.
20. BURNS JC, SHIMIZU C, GONZALES E et al.: Genetic variations in the receptor-ligand pair CCR5 and CCL3L1 are important determinants of susceptibility to Kawasaki disease. J Infect Dis 2005; 192: 344-9.
21. ONOUCHI Y, GUNJI T, BURNS JC et al.: ITPKC functional polymorphism associated with Kawasaki disease susceptibility and formation of coronary artery disease. Nat Genet 2008; 40: 35-42.
22. AMIN MA, VOLPERT OV, WOODS JM, KUMAR P, HARLOW LA, KOCH AE: Migration inhibitory factor mediates angiogenesis via mitogen-activated protein kinase and phosphatidyl inositol kinase. Circ Res 2003; 93: 321-9.
23. AMIN MA, HAAS CS, ZHU K, MANSFIELD PJ, KIM MJ, LACKOWSKI NP, KOCH AE: Migration inhibitory factor up-regulates vascular cell adhesion molecule-1 and intercellular adhesion molecule-1 via Src, PI3 kinase and NFkB. Blood 2006; 107: 2252-61.